The China Advanced Therapy Opportunity.

China has become one of the fastest-growing cell and gene therapy markets in the world, with a rapidly expanding pipeline, significant investment, and a growing number of clinical trials. However, regulatory complexity and market access challenges still shape how international collaboration unfolds. This session brings together Chinese biotech leaders and global investors to explore partnership opportunities, technology exchange, and how companies can navigate collaboration between China and emerging biotech regions